Minimal Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar and Lumbosacral Spine Diseases

ConditionDegenerative Spine Diseases

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-65

SponsorSohag University

About this trial

The aim of this study is to evaluate clinical and surgical outcome of MI-TLIF for degenerative lumbar and lumbosacral spine diseases.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Degenerative spondylolisthesis.

Degenerative unilateral disc herniations.

Recurrent disc herniation.

Disqualifiers

Spondylolisthesis Grade III or IV.

Degenerative scoliosis .

Traumatic fracture spine.

Infections.

Trial design

Design model

Single group

Treatments tested in this trial

lumbar fusion
Procedure/Surgery
Minimal Invasive Transforaminal Lumbar Interbody Fusion

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

severity of pain according to visual analog score(vas)

comparison between pre \& post operative pain

Time frame

1 year

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: